Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-day monotherapy of UK-453,061 in asymptomatic HIV-1 infected patients
2005-004120-39Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing UK-453,061 monotherapy with Placebo (2 arms). Primary endpoint: HIV viral load. Started Oct 2005; status: completed.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-004120-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004120-39.